Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 14.7% – What’s Next?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) traded up 14.7% during mid-day trading on Friday . The company traded as high as C$0.20 and last traded at C$0.20. 485,000 shares traded hands during trading, an increase of 25% from the average session volume of 389,063 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 11.8 %

The firm has a 50 day moving average price of C$0.09 and a 200-day moving average price of C$0.07. The firm has a market cap of C$26.50 million, a price-to-earnings ratio of -19.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Recommended Stories

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.